325 related articles for article (PubMed ID: 32346744)
41. Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck.
Varra V; Smile TD; Geiger JL; Koyfman SA
Curr Treat Options Oncol; 2020 Apr; 21(5):37. PubMed ID: 32328817
[TBL] [Abstract][Full Text] [Related]
42. Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?
Wessely A; Steeb T; Leiter U; Garbe C; Berking C; Heppt MV
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291277
[TBL] [Abstract][Full Text] [Related]
43. EAU guidelines on penile cancer: 2014 update.
Hakenberg OW; Compérat EM; Minhas S; Necchi A; Protzel C; Watkin N
Eur Urol; 2015 Jan; 67(1):142-150. PubMed ID: 25457021
[TBL] [Abstract][Full Text] [Related]
44. Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma.
Giri A; Bauman JR
Expert Rev Anticancer Ther; 2022 Oct; 22(10):1029-1038. PubMed ID: 36106496
[TBL] [Abstract][Full Text] [Related]
45. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient With Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review.
Antonelli JP; Quach M; Mahajan A; Pleva J; Ma VT
J Immunother; 2024 Jul-Aug 01; 47(6):216-219. PubMed ID: 38532708
[TBL] [Abstract][Full Text] [Related]
46. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients.
Chapalain M; Baroudjian B; Dupont A; Lhote R; Lambert J; Bagot M; Lebbe C; Basset-Seguin N
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1202-1209. PubMed ID: 31587382
[TBL] [Abstract][Full Text] [Related]
47. Case Report:
Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH
Front Immunol; 2021; 12():752563. PubMed ID: 35003064
[TBL] [Abstract][Full Text] [Related]
48. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
49. Treatment of advanced cutaneous squamous cell carcinoma: a Mohs surgery and dermatologic oncology perspective.
Wilmas KM; Nguyen QB; Patel J; Silapunt S; Migden MR
Future Oncol; 2021 Dec; 17(35):4971-4982. PubMed ID: 34608809
[TBL] [Abstract][Full Text] [Related]
50. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes.
Veness MJ; Porceddu S; Palme CE; Morgan GJ
Head Neck; 2007 Jul; 29(7):621-31. PubMed ID: 17230560
[TBL] [Abstract][Full Text] [Related]
51. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
52. Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study.
Salzmann M; Leiter U; Loquai C; Zimmer L; Ugurel S; Gutzmer R; Thoms KM; Enk AH; Hassel JC
Eur J Cancer; 2020 Oct; 138():125-132. PubMed ID: 32882466
[TBL] [Abstract][Full Text] [Related]
53. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review.
Newman JG; Hall MA; Kurley SJ; Cook RW; Farberg AS; Geiger JL; Koyfman SA
Head Neck; 2021 Sep; 43(9):2822-2843. PubMed ID: 34096664
[TBL] [Abstract][Full Text] [Related]
55. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
56. Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.
Keeping S; Xu Y; Chen CI; Cope S; Mojebi A; Kuznik A; Konidaris G; Ayers D; Sasane M; Allen R; Huynh TM; Popoff E; Freeman M; Andria ML; Fury MG; Singh K; Stockfleth E; Challapalli A; Schmults CD
Future Oncol; 2021 Feb; 17(5):611-627. PubMed ID: 33052055
[No Abstract] [Full Text] [Related]
57. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
[TBL] [Abstract][Full Text] [Related]
59. Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma - a systematic review.
Heppt MV; Steeb T; Berking C; Nast A
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():25-32. PubMed ID: 31833609
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
